[
  {
    "ts": null,
    "headline": "Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program",
    "summary": "Conference Call Scheduled for 8:30 AM EDT Today, August 7, 2025SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced its financial results for second quarter 2025. “This quarter represents a significant step forward for Achieve. After year",
    "url": "https://finnhub.io/api/news?id=1705d645bf94af890ed6f09bff10d5e4296ca2940568555e3cc6d2144187d589",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754566200,
      "headline": "Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program",
      "id": 136246931,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "OMC",
      "source": "Yahoo",
      "summary": "Conference Call Scheduled for 8:30 AM EDT Today, August 7, 2025SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced its financial results for second quarter 2025. “This quarter represents a significant step forward for Achieve. After year",
      "url": "https://finnhub.io/api/news?id=1705d645bf94af890ed6f09bff10d5e4296ca2940568555e3cc6d2144187d589"
    }
  },
  {
    "ts": null,
    "headline": "FleishmanHillard Appoints New Global Corporate Affairs Leadership",
    "summary": "As companies face rising volatility, stakeholder scrutiny and operational complexity, the role of corporate affairs has become an increasingly critical issue for the C-suite. To meet this moment, FleishmanHillard today announced a new Corporate Affairs Practice leadership structure to deliver more connected, insight-driven counsel and stay ahead of the demands of today's global business environment.",
    "url": "https://finnhub.io/api/news?id=0667c514a9396d97089c645215ccd7553f75e686d6acd039f9b9db4396916acc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754566200,
      "headline": "FleishmanHillard Appoints New Global Corporate Affairs Leadership",
      "id": 136246930,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "OMC",
      "source": "Yahoo",
      "summary": "As companies face rising volatility, stakeholder scrutiny and operational complexity, the role of corporate affairs has become an increasingly critical issue for the C-suite. To meet this moment, FleishmanHillard today announced a new Corporate Affairs Practice leadership structure to deliver more connected, insight-driven counsel and stay ahead of the demands of today's global business environment.",
      "url": "https://finnhub.io/api/news?id=0667c514a9396d97089c645215ccd7553f75e686d6acd039f9b9db4396916acc"
    }
  }
]